The Blood Cancer Center at The Jewish Hospital - Mercy Health Performs its 2000th Bone Marrow Transplant

Mercy Health - Cincinnati, which provides advanced, compassionate, quality care in your neighborhood through its care network, announces that cancer experts with the Blood Cancer Center at The Jewish Hospital performed the center's 2000th transplant at 11 a.m. on Friday, September 16.

The care team and patient Stacey Cass, 59, of Fairfield, Ohio, who has multiple myeloma, took a moment to celebrate the milestone and more than 20 years of saving lives thanks to clinical and research excellence.

"The Blood Cancer Center is the most advanced adult blood and bone marrow transplant program in the Tristate and its overall patient survival rates rival those of MD Anderson and the Cleveland Clinic and are ahead of noted facilities such as Cedars Sinai and the Mayo Clinic," said Pat Davis-Hagens, Mercy Health Central Market President and CEO of The Jewish Hospital. "I congratulate this team on their tremendous achievement which has impacted the lives of so many individuals and their families in the region."

Mercy Health partners with OHC, the largest group of independent oncologists and hematologists in the Tristate, to provide care at the Blood Cancer Center.

"Today was a great day for Stacey Cass but an even greater day for the Blood Cancer Center team. This is a milestone that symbolizes the hard work of this team for over 20 years," said James H. Essell, MD, OHC hematologist-oncologist and medical director of the Blood Cancer Center.

Nationally recognized and accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), the Blood Cancer Center has earned the Gold Seal of Approval® from the Joint Commission—a disease-specific care certification.

The state-of-the-art transplant facility includes 28 private rooms, six of which are ICU rooms designated for blood cancer patients requiring critical care. An acute rehabilitation unit, outpatient clinic and infusion center are also located on the same floor as the inpatient unit providing ease of access for both patients and caregivers.

To date in 2016, The Jewish Hospital Blood Cancer Center performed 64 transplants and it has completed 2,000 since opening in 1993. Each year, the team treats more than 120 new patients with acute leukemia and high grade lymphoma with procedures including autologous, allogeneic, syngeneic (from an identical twin) and haplo-identical (half matched donor) transplants. The Jewish Hospital Blood Cancer Center participates in a wide range of research studies, giving patients access to leading-edge treatments and clinical trials as soon as they are available.